Related Experiment Videos
[Transforming growth factor-beta signaling and cancer]
1Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033 Japan.
Abstract:
Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that inhibits the growth of most types of cells and induces fibrosis of various tissues. TGF-beta binds to two different types of serine/threonine kinase receptors, and activate Smad proteins. Perturbation of the TGF-beta signaling pathway results in tumorigenesis of various tissues. TGF-beta/Smad signaling is regulated by several regulatory proteins, including inhibitory Smads and transcriptional corepressors. Abnormalities in these negative regulators of TGF-beta signaling may also involved in tumorigenesis of certain tissues.
Insights
Transforming growth factor-beta (TGF-beta) inhibits cell growth and causes fibrosis. Dysregulation of its signaling pathway, including negative regulators, contributes to cancer development.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Context:
- Transforming growth factor-beta (TGF-beta) is a key cytokine regulating cell growth, differentiation, and tissue homeostasis.
- TGF-beta exerts its functions by binding to serine/threonine kinase receptors, initiating intracellular signaling cascades.
- The TGF-beta/Smad pathway is crucial for normal cellular processes, and its dysregulation is implicated in various diseases.
Purpose:
- To elucidate the role of TGF-beta signaling in cellular processes.
- To investigate the mechanisms by which TGF-beta regulates cell growth and fibrosis.
- To understand the contribution of TGF-beta pathway perturbations to tumorigenesis.
Summary:
- TGF-beta is a multifunctional cytokine that inhibits cell proliferation and promotes fibrosis.
- Activation of TGF-beta signaling occurs through specific cell surface receptors, leading to the activation of Smad proteins.
- Aberrant TGF-beta/Smad signaling, potentially due to defects in negative regulators like inhibitory Smads and corepressors, is linked to the development of various cancers.
Impact:
- Understanding TGF-beta signaling is critical for developing therapeutic strategies against fibrosis and cancer.
- Identifying the role of negative regulators in TGF-beta pathway dysfunction offers potential targets for cancer therapy.
- This research contributes to the fundamental knowledge of cell signaling and its implications in disease pathogenesis.